Release Date: 03/02/09 09:58 Summary: Acceptance of SAI's Offer by LUT Investments Price Sensitive: Yes Download Document 109.06KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%